This site is under development. For the current active site, go to bcbhub.csic.es.

Orcid Publication

Detalle de: In Silico Assessment of the Lipid Fingerprint Signature of ATP2, the Essential P4-ATPase of Malaria Parasites

Title In Silico Assessment of the Lipid Fingerprint Signature of ATP2, the Essential P4-ATPase of Malaria Parasites
Abstract

ATP2, a putative type 4 P-type ATPase, is a phosphatidylinositol-4-phosphate (PI4P)-regulated phospholipid transporter with an interesting potential as an antimalarial drug target due to its conservation across Plasmodium species and its essential role in the life cycle of Plasmodium falciparum. Despite its importance, the exact mechanism of its action and regulation is still not fully understood. In this study we used coarse-grained molecular dynamics (CG-MD) to elucidate the lipid–protein interactions between a heterogeneous lipid membrane containing phosphatidylinositol and Plasmodium chabaudi ATP2 (PcATP2), an ortholog of P. falciparum ATP2. Our study reveals structural information of the lipid fingerprint of ATP2, and provides structural information on the potential phosphatidylinositol allosteric binding site. Moreover, we identified a set of evolutionary conserved residues that may play a key role in the binding and stabilization of lipids in the binding pocket.

Apa Reference López-Martín, M., Renault, P., Giraldo, J., Vázquez-Ibar, J. L., & Perálvarez-Marín, A. (2022). In Silico Assessment of the Lipid Fingerprint Signature of ATP2, the Essential P4-ATPase of Malaria Parasites. Membranes, 12(7), 702. 10.3390/membranes12070702
Doi 10.3390/membranes12070702
Publication Date 12 Jul 2022
Publication Type Article
Researcher Mario López Martín
Ontology Molecular flexibility, Computational models and simulations, Biomolecular simulation, Molecular Interactions/Docking
Research Groups Protein Design and Modeling, Synthetic Structural Biology
Tools

Suggest changes

Publications are synced automatically from ORCID, so they can't be edited here directly. Spotted something wrong? Let us know below and we'll take care of it.

← Return to Home